Unique human immune signature of Ebola virus disease in Guinea.
about
Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor FunctionEnabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani.Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus.Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination.Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.Ebola Virus Disease in Humans: Pathophysiology and Immunity.Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.Considerations for use of Ebola vaccine during an emergency response.Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.Filovirus Strategies to Escape Antiviral Responses.Humanized Mice Reproduce Acute and Persistent Human Adenovirus Infection.Sepsis in PD-1 light.Host Transcriptional Response to Ebola Virus Infection.Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System.Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus Macaques.Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis.Immune barriers of Ebola virus infection.Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria.Disabling of lymphocyte immune response by Ebola virus.A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategiesDeficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection
P2860
Q28109688-F192A756-B2DC-4710-A9AB-345418705827Q30151599-3DFAE77C-9836-4071-9777-EC3722BAD0BDQ33715773-082D47FC-5357-41A1-BDA0-06F8D71DFFFEQ33803364-D1DC5BFA-5D31-4548-A5FA-A0798C3A817DQ36178499-7EA5012F-1100-49BF-A3C5-E1DEEC33EDB9Q36216308-4FF713DD-A3F2-4FBD-967F-A23FCC919B80Q37593571-9ED8C206-CF14-4D21-8551-15B718071AF1Q37678872-6C318B58-6E7F-4FFA-B9EA-3B2C60C59A0CQ38598481-AFADCAB1-73B2-4370-98F5-6C2C1E4B035AQ38603013-C7892077-3374-413E-8DF5-D0E027987230Q38707770-C64B363A-4E9A-4C58-8619-C42332697CE0Q38711125-6A51011F-2602-4B00-A21A-966F07406FE0Q38848150-B9F9E6D1-DB54-4FDD-A0EE-DE77102F0D19Q40039769-95226014-1C24-4BD9-B10E-C5B9F02DBF3AQ40061262-4C49D13C-5BDB-4C6C-997A-2ED9FD6E9B95Q40132236-8E2EF0D7-ABFD-4576-9240-95DCC3ABAB7DQ40375992-DD7D3CE1-C79C-4319-ADC0-F39B6F6E6D91Q40625575-FD36A40C-315F-4DFE-9FD5-EBA8578D8959Q41905593-3DE3F35A-3105-475F-9814-B275EC61AF60Q41919588-F2A13257-DC15-4D91-A074-759453FF0652Q44106105-5BFA6D03-4BEB-4CAE-8475-057E00FCF2C1Q44106136-2C813F03-3C8C-4554-B5B5-09DC371BAF53Q49917351-3436B0C3-2697-48DC-902E-BB1FF02995A8Q52647950-BDCEDB1F-EACD-48A2-B90E-E7EC3C51D782Q54107921-3C895ED9-5345-44F1-BA36-004952F3F46AQ55286894-BB7A2C35-0F89-406C-AAEF-CB417F4861ACQ57059911-350545C9-F254-40D1-A9D5-31C35964ABDEQ58765534-6E130659-22E8-4DB1-84F7-A681A3E47AE0
P2860
Unique human immune signature of Ebola virus disease in Guinea.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Unique human immune signature of Ebola virus disease in Guinea.
@ast
Unique human immune signature of Ebola virus disease in Guinea.
@en
Unique human immune signature of Ebola virus disease in Guinea.
@nl
type
label
Unique human immune signature of Ebola virus disease in Guinea.
@ast
Unique human immune signature of Ebola virus disease in Guinea.
@en
Unique human immune signature of Ebola virus disease in Guinea.
@nl
prefLabel
Unique human immune signature of Ebola virus disease in Guinea.
@ast
Unique human immune signature of Ebola virus disease in Guinea.
@en
Unique human immune signature of Ebola virus disease in Guinea.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Unique human immune signature of Ebola virus disease in Guinea.
@en
P2093
Alexandra Fizet
Amadou Bah
Anabel Negredo
Andreas Kurth
Andreas Sachse
Anja Lüdtke
Anja Thorenz
Anne Bocquin
Anne Kelterbaum
Ansgar W Lohse
P2860
P2888
P304
P356
10.1038/NATURE17949
P407
P50
P577
2016-05-01T00:00:00Z